Sandler Laura Lee

Chief Operating OfficerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Sep 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$459K
Net Open-Market Flow
-$459K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)5K$7.80$39K241K
Sep 1, 2026Sell(S)1K$91.05$91K240K
Sep 1, 2026Sell(S)4K$92.01$368K236K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)5K$075K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000088) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.